Micromedic Reports Success with CellDetect™ for Detecting Cervical Cancer in a Pilot Study at a Central Hospital in Beijing, Receives Order for 100,000 Detection Kits

Micromedic reported positive results from a post marketing pilot study conducted in a central hospital in Beijing using the CellDetect™ product for the detection and identification of cervical cancer. The Company also announced receipt of an order for the purchase of 100,000 cervical cancer detection kits from its strategic partner in China, Biomics Co., which builds upon  the first commercial order from Biomics for 20,000 kits.

Link to the complete article

Link to Newsroom

Comments are closed.